[Treatment of inflammatory diseases of the mouth and throat with Larypront in ENT practice (author's transl)].
Treatment of inflammations of the oral and pharyngeal cavities (glossitis, pharyngitis, pharyngolaryngitis, tonsillitis) in 60 patients with Larypront Throat Tablets alone, without administration of systemic antibiotics, gave very good results in 49 cases (81.6%) with complete regression of the complaints in 3-4 days. In 11 patients with acute pharyngitis and tonsillitis without demonstrable effect, systemic antibiotic therapy had to be added because of radiologically demonstrable acute sinusitis or increasing antibacterial infection. Side effects were not seen with the use of Larypront in any case.
D000293:Adolescent; D000328:Adult; D000368:Aged; D003868:Dequalinium / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005928:Glossitis / Q000188:drug therapy*; D006801:Humans; D007827:Laryngitis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009113:Muramidase / Q000627:therapeutic use*; D011806:Quinolinium Compounds / Q000627:therapeutic use*; D014069:Tonsillitis / Q000188:drug therapy*
D004338:Drug Combinations; D011806:Quinolinium Compounds; D003868:Dequalinium; D009113:Muramidase
Behandlung entzündlicher Mund- und Rachenerkrankungen mit Larypront in der HNO-Praxis